| DC Field | Value | Language |
|---|
| dc.contributor.author | Denisuk, T. A. | - |
| dc.contributor.author | Pokrovskii, M. V. | - |
| dc.contributor.author | Philippova, O. V. | - |
| dc.contributor.author | Dolzhikov, A. A. | - |
| dc.contributor.author | Pokrovskaia, T. G. | - |
| dc.contributor.author | Korokin, M. V. | - |
| dc.contributor.author | Gudyrev, O. S. | - |
| dc.date.accessioned | 2024-11-12T12:53:21Z | - |
| dc.date.available | 2024-11-12T12:53:21Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | Endothelio- and cardioprotective effects of HMG-CoA reductase inhibitors under the condition of endotoxin-induced endothelial dysfunction / T.A. Denisuk, M.V. Pokrovskii, O.V. Philippova [et al.] // Research Journal of Pharmaceutical, Biological and Chemical Sciences. - 2015. - Vol.6, №5.-P. 1542-1547. - Refer.: p. 1546-1547. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/63915 | - |
| dc.description.abstract | Application of the HMG-CoA reductase inhibitors, such as simvastatin, atorvastatin, rosuvastatin and nanocapsular rosuvastatin, leads to dose response endothelioprotective effect under the condition of endotoxin-induced endothelial dysfunction after administration of the staphylococcus aureus strain 603 | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | endothelial dysfunction | ru |
| dc.subject | HMG-CoA reductase inhibitors | ru |
| dc.subject | simvastatin | ru |
| dc.subject | atorvastatin | ru |
| dc.subject | rosuvastatin | ru |
| dc.subject | endotoxin | ru |
| dc.title | Endothelio- and cardioprotective effects of HMG-CoA reductase inhibitors under the condition of endotoxin-induced endothelial dysfunction | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
